Xiangxue Pharmaceutical Co.,Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300147
  • 1d-3.49%
  • 1w-3.97%
  • 1m-11.44%
  • 1y-31.38%
ATH
  • ATH Price$38.62
  • ATH Date2015-06-03
  • % since ATH-89.98%
  • % to ATH898.00%
ATL
  • ATL Price$3.07
  • ATL Date2024-02-07
  • % from ATL26.06%
  • Last Low Price$3.07
  • Last Low Date2024-02-07
  • % From Last Low26.06%
IPO
  • IPO Price$33.11
  • % Current ROI USD-88.31%
  • ATH Price$38.62
  • % ROI ATH 125,806.51%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300147"]

Key Data [addtoany]

Current price $3.87
Sector Healthcare
Industry Biotechnology
Today's High/Low $4.03/$3.85
Volume 15,517,000.00
Previous Close $4.01
52 Week High/Low $6.45/$3
Market Cap 2,559,149,568.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$3.87
[addtoany]

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China.
It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China’s traditional Chinese medicine industry. The company was founded in 1997 and is based in Guangzhou, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity